Longitude Capital
Trudy (Geertrui) Vanhove, MD, PhD, currently serves as a Venture Partner at Longitude Capital and as a member of the Board of Directors at Ziphius. Trudy owns Biophare Consulting LLC and previously held the position of Chief Medical Officer at Surrozen, a company focused on developing regenerative medicines targeting the Wnt signaling pathway essential for stem cell maintenance and tissue regeneration. Prior roles include Vice President at Jazz Pharmaceuticals and Depomed, Inc., as well as Vice President of Clinical Development at NeurogesX, Inc. Trudy also served as a Senior Investment Manager at GIMV and as Medical Director at XOMA (US) LLC. Educational qualifications include a PhD in Pharmacology and an MD from KU Leuven, a postdoctoral fellowship in Clinical Pharmacology from Stanford University School of Medicine, an MBA from Saint Mary's College of California, and an ongoing certificate program in Artificial Intelligence in Pharma and Biotech from MIT Sloan School of Management.
This person is not in the org chart
This person is not in any teams
Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. Longitude Capital invests in both privately held and publicly traded life science companies through a variety of investment approaches.